Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNS Marinus Pharmaceuticals

盘前交易 05-16 09:15:19 EDT

1.33

-0.01

-0.75%

盘前1.37

+0.04+3.02%

09:08 EDT

最高1.45	最低1.33	成交量107.96万
今开1.35	昨收1.34	日振幅8.96%
总市值7,306万	流通市值5,119万	总股本5,493万
成交额148.68万	换手率2.80%	流通股本3,849万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":1.33,"timestamp":1715803200000,"preClose":1.34,"halted":0,"volume":1079563,"hourTrading":{"tag":"盘前","latestPrice":1.3701,"preClose":1.33,"latestTime":"09:08 EDT","volume":14198,"amount":19270.154571400002,"timestamp":1715864910838},"delay":0,"floatShares":38490200,"shares":54933774,"eps":-2.642427,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.01,"latestTime":"05-16 09:15:19 EDT","open":1.35,"high":1.45,"low":1.33,"amount":1486820.1529838,"amplitude":0.089552,"askPrice":1.39,"askSize":200,"bidPrice":1.34,"bidSize":363,"shortable":3,"etf":0,"ttmEps":-2.642427,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715866200000},"adr":0,"listingDate":1406779200000,"adjPreClose":1.33,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.3701,"preClose":1.33,"latestTime":"09:08 EDT","volume":14198,"amount":19270.154571400002,"timestamp":1715864910838},"postHourTrading":{"tag":"盘后","latestPrice":1.3398,"preClose":1.33,"latestTime":"19:54 EDT","volume":7904,"amount":10636.1304,"timestamp":1715817252828},"volumeRatio":0.6919337982507452,"optionData":{"bulkOrders":[{"symbol":"MRNS","call":false,"expireDate":1715918400000,"strike":"2.0","timestamp":1715795086228,"price":0.6499999761581421,"volume":5706,"amount":370890,"type":"+"},{"symbol":"MRNS","call":false,"expireDate":1715918400000,"strike":"2.0","timestamp":1715795086228,"price":0.699999988079071,"volume":3803,"amount":266210,"type":"-"}]}},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2434854029","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854029","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434854029?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:56","pubTimestamp":1715349369,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.05%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。消息层面，截至21时56分，《HC Wainwright & Co.：维持Marinus Pharma评级，由买入调整至买入评级, 目标价由27.00美元调整至11.00美元。》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021561079270775&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021561079270775&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434594580","title":"美国研究综述-新月能源、罗克韦尔自动化、Transdigm 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2434594580","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434594580?lang=zh_cn&edition=full","pubTime":"2024-05-09 14:54","pubTimestamp":1715237640,"startTime":"0","endTime":"0","summary":"    路透5月9日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，包括新月能源、罗克韦尔自动化和 Transdigm 集团。要闻              * 新月能源  ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。* Transdigm Group Inc   ：摩根大通将目标价从1175美元上调至1350美元  以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433248587","title":"Marinus Pharmaceuticals Inc 报告截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433248587","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433248587?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:53","pubTimestamp":1715176421,"startTime":"0","endTime":"0","summary":"   * Marinus Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损68美分，低于去年同期的每股收益-67美分。11 位分析师对该季度的平均预期是每股亏损 66 美分。华尔街预期为每股-79美分至-61美分。* 营收同比下降 26.2%，降至 766 万美元；分析师预期为 913 万美元。* Marinus Pharmaceuticals Inc公布的本季度每股收益为亏损68美分。* Marinus Pharmaceuticals Inc 本季度股价下跌了 82.6%，今年迄今为止下跌了 85.6%。* 华尔街对 Marinus Pharmaceuticals Inc 的 12 个月目标价中位数为 7.50 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433780687","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433780687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433780687?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:40","pubTimestamp":1715100027,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日00时40分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。消息层面，截至00时40分，《HC Wainwright & Co.：维持Marinus Pharma评级，由买入调整至买入评级, 目标价由27.00美元调整至11.00美元。》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050800402887e862bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050800402887e862bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433678659","title":"HC Wainwright & Co.：维持Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433678659","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433678659?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:07","pubTimestamp":1715090820,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722070287dcb3e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722070287dcb3e0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432083359","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432083359","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432083359?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743192,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.52%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为66.88%、22.09%、11.02%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133127925c0c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133127925c0c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113603","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113603","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113603?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:52","pubTimestamp":1713880354,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时52分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.08%。截至发稿，该股报1.55美元/股，成交量35.4902万股，换手率0.65%，振幅7.12%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Palisade Bio, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Carmell Corporation涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为1432.49%、165.54%、25.43%，振幅较大的相关个股有Palisade Bio, Inc.、Immunitybio, Inc.、Moolec Science Sa C/Wts ，振幅分别为32.86%、25.10%、23.24%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232152357a54ee8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232152357a54ee8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429273729","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429273729","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429273729?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:04","pubTimestamp":1713794642,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时04分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.07%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为151.43%、51.09%、41.41%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为175.74%、68.57%、25.74%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222040287e82835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222040287e82835&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428525046","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.67%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428525046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428525046?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:40","pubTimestamp":1713534009,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时40分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.67%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。消息层面，截至21时40分，《Truist Securities：维持Marinus Pharma评级，由买入调整至买入评级, 目标价由25.00美元调整至10.00美元。》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419214010861e774b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419214010861e774b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428334687","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.56%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428334687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428334687?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:35","pubTimestamp":1713447357,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时35分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.56%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。消息层面，截至21时35分，《Truist Securities：维持Marinus Pharma评级，由买入调整至买入评级, 目标价由25.00美元调整至10.00美元。》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821355787e81bb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041821355787e81bb9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428824436","title":"Truist Securities：维持Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价由25.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428824436","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428824436?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:25","pubTimestamp":1713439525,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价由25.00美元调整至10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181925308b35d8f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181925308b35d8f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427798658","title":"HC Wainwright & Co.：重申Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427798658","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427798658?lang=zh_cn&edition=full","pubTime":"2024-04-16 23:05","pubTimestamp":1713279951,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Marinus Pharma(MRNS.US)评级，由买入调整至买入评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162305538b2adc61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162305538b2adc61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427247820","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨12.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427247820","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427247820?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:32","pubTimestamp":1713274346,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时32分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速上涨12.31%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。消息层面，截至21时32分，《加拿大皇家银行：下调Marinus Pharma评级，由优于大市调整至与大盘持平评级, 目标价由24.00美元调整至3.00美元。》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132268b2a98b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162132268b2a98b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427838166","title":"加拿大皇家银行：下调Marinus Pharma(MRNS.US)评级，由优于大市调整至与大盘持平评级, 目标价由24.00美元调整至3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427838166","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427838166?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:05","pubTimestamp":1713207907,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：下调Marinus Pharma(MRNS.US)评级，由优于大市调整至与大盘持平评级, 目标价由24.00美元调整至3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160305118b2738bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160305118b2738bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427051300","title":"Marinus Pharmaceuticals, Inc.股价重挫74.53% 市值跌7840.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427051300","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427051300?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187883,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速跳水74.53%。截至发稿，该股报1.92美元/股，成交量536.817万股，换手率9.77%，振幅0.93%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为582.80%、339.78%、253.82%，振幅较大的相关个股有Organovo Holdings, Inc.、Soligenix, Inc.、Vaxxinity, Inc.，振幅分别为28.71%、16.32%、9.83%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131238b263f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131238b263f1f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427072585","title":"BUZZ-由于癫痫发作药物未能达到研究的提前终止标准，Marinus公司陷入困境","url":"https://stock-news.laohu8.com/highlight/detail?id=2427072585","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427072585?lang=zh_cn&edition=full","pubTime":"2024-04-15 20:08","pubTimestamp":1713182926,"startTime":"0","endTime":"0","summary":"** 截至上一交易日收盘，股价累计下跌约 31","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427071726","title":"嗡嗡声--美国股票走势-Longeveron、Novavax、Telsa","url":"https://stock-news.laohu8.com/highlight/detail?id=2427071726","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427071726?lang=zh_cn&edition=full","pubTime":"2024-04-15 19:47","pubTimestamp":1713181664,"startTime":"0","endTime":"0","summary":"    4月15日 - 周一，美国股指期货上涨，此前由于美国一些大银行的盈利令人失望，华尔街在上一交易日出现了严重的抛售，而中东地区不断升级的紧张局势也令投资者保持警惕。标准普尔500指数小型股  上涨0.49%，报5,192.75点；纳斯达克100指数小型股  上涨0.55%，报18,279.25点。因获得北卡罗来纳州项目许可而上涨    ** Neumora Therapeutics   ：盘前下跌 13.7 因美国 FDA 暂停精神分裂症药物研究而下跌   ** Blackbaud   ：盘前上涨2.7%。因Clearlake Capital提高收购报价而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427475430","title":"Marinus Pharmaceuticals, Inc.盘中异动 下午盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427475430","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427475430?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:20","pubTimestamp":1712949633,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时20分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报7.52美元/股，成交量34.157万股，换手率0.62%，振幅5.81%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.69%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Q32 Bio Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3748.79%、1491.56%、108.68%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为93.97%、74.01%、63.12%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413032034861e5617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413032034861e5617&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426417858","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.67%报7.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426417858","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426417858?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:10","pubTimestamp":1712765451,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日00时10分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.67%。截至发稿，该股报7.91美元/股，成交量14.6031万股，换手率0.27%，振幅4.18%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Adial Pharmaceuticals, Inc、Orgenesis Inc.、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1904.13%、76.40%、49.17%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ，振幅分别为87.61%、74.23%、52.44%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041100105187e7f583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041100105187e7f583&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492310","title":"Marinus Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492310","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492310?lang=zh_cn&edition=full","pubTime":"2024-04-09 03:38","pubTimestamp":1712605115,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日03时38分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.00%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为2243.48%、1945.89%、95.24%，振幅较大的相关个股有Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、阿诺医药，振幅分别为142.73%、94.40%、83.69%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040903383587e7e9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040903383587e7e9ad&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0699},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.867},{"period":"6month","weight":-0.7844},{"period":"1year","weight":-0.8437},{"period":"ytd","weight":-0.8776}],"compareEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0502},{"period":"3month","weight":0.0553},{"period":"6month","weight":0.1752},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.1146}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司，专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子，它是异孕烯醇的合成类似物，异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体，调节大脑神经递质γ-氨基丁酸（GABA）。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法，用于治疗成人癫痫患者部分发作（也称为局灶性发作）。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验，表明与添加安慰剂的患者相比，在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验，该公司打算扩大该试验，以便在向美国食品和药物管理局（FDA）或欧洲药品管理局（EMA）提交的关于加那索龙治疗癫痫的注册文件中，作为其充分且受控的临床试验之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037828},{"month":2,"riseRate":0.6,"avgChangeRate":-0.012045},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013524},{"month":6,"riseRate":0.555556,"avgChangeRate":0.058242},{"month":7,"riseRate":0.555556,"avgChangeRate":0.002733},{"month":8,"riseRate":0.5,"avgChangeRate":0.032608},{"month":9,"riseRate":0.6,"avgChangeRate":0.189829},{"month":10,"riseRate":0.3,"avgChangeRate":-0.14351},{"month":11,"riseRate":0.4,"avgChangeRate":0.025431},{"month":12,"riseRate":0.6,"avgChangeRate":0.123461}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}